Core Biogenesis
PrivateLast Round
Series A
Jul 28, 2022
Total Funding Raised
$13.66M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Core Biogenesis is a biotechnology company that develops a plant-based bioproduction platform to manufacture recombinant proteins for the cell therapy, cellular agriculture, and skincare industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Core Biogenesis Comparables
Compare Core Biogenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ORF Genetics | 85% | |
| Bright Biotech | 83% | |
| BioBetter | 83% |
Core Biogenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2022 | ||||
| Seed | Dec 14, 2020 |
Key People
Founding team and executive leadership
Core Biogenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| Thia Ventures | Series A |
| XAnge | Seed, Series A |
| Entrepreneurs First | Seed, Series A |
| Blue Horizon Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 896% MoM.
- Jul 20, 2026
Open roles increased from 0 to 9, representing 29% of headcount.
Recent news
Latest coverage and updates
- partners_withAug 31, 2026
Core Biogenesis SAS partners with Faravelli Group.
Core Biogenesis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Core Biogenesis's valuation, stock price, and market status.
Is Core Biogenesis a public or private company?
Core Biogenesis is a private company.
What is the current stock price of Core Biogenesis?
Core Biogenesis is a private company with no public stock price. No recent secondary market data is available.
How much is Core Biogenesis worth (valuation)?
Valuation information for Core Biogenesis is not publicly available.
Can I buy Core Biogenesis stock?
Core Biogenesis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Core Biogenesis's last funding round?
Core Biogenesis's most recent funding round was Series A on July 28, 2022.
Who are the main investors in Core Biogenesis?
Key investors in Core Biogenesis include XAnge.
Will Core Biogenesis IPO soon?
No public IPO plans have been announced for Core Biogenesis.
How can I track Core Biogenesis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Core Biogenesis's secondary market activity and sign up for updates.